Format

Send to:

Choose Destination
See comment in PubMed Commons below
Gut. 2013 May;62(5):766-73. doi: 10.1136/gutjnl-2012-302344. Epub 2012 Jul 17.

Vitamin B12 supplementation improves rates of sustained viral response in patients chronically infected with hepatitis C virus.

Author information

  • 1Department of Clinical and Experimental Medicine, Gastroenterology Unit, University of Naples Federico II, via Pansini 5, 80131 Naples, Italy.

Abstract

BACKGROUND:

In vitro, vitamin B12 acts as a natural inhibitor of hepatitis C virus (HCV) replication.

OBJECTIVE:

To assess the effect of vitamin B12 on virological response in patients with chronic HCV hepatitis naïve to antiviral therapy.

METHODS:

Ninety-four patients with chronic HCV hepatitis were randomly assigned to receive pegylated interferon α plus ribavirin (standard-of-care; SOC) or SOC plus vitamin B12 (SOC+B12). Viral response-namely, undetectable serum HCV-RNA, was evaluated 4 weeks after starting treatment (rapid viral response), 12 weeks after starting treatment (complete early viral response) and 24 or 48 weeks after starting treatment (end-of-treatment viral response) and 24 weeks after completing treatment (sustained viral response (SVR)). Genotyping for the interleukin (IL)-28B polymorphism was performed a posteriori in a subset (42/64) of HCV genotype 1 carriers.

RESULTS:

Overall, rapid viral response did not differ between the two groups, whereas the rates of complete early viral response (p=0.03), end-of-treatment viral response (p=0.03) and SVR (p=0.001) were significantly higher in SOC+B12 patients than in SOC patients. In SOC+B12 patients, the SVR rate was also significantly higher in carriers of a difficult-to-treat genotype (p=0.002) and in patients with a high baseline viral load (p=0.002). Distribution of genotype IL-28B did not differ between the two groups. At multivariate analysis, only easy-to-treat HCV genotypes (OR=9.00; 95% CI 2.5 to 37.5; p=0.001) and vitamin B12 supplementation (OR=6.9; 95% CI 2.0 to 23.6; p=0.002) were independently associated with SVR.

CONCLUSION:

Vitamin B12 supplementation significantly improves SVR rates in HCV-infected patients naïve to antiviral therapy.

PMID:
22810757
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Write to the Help Desk